ACZONE is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Almirall, Llc. The primary component is Dapsone.
| Product ID | 16110-367_4b6c672f-a7c3-4123-8f64-c08b3d7ae906 |
| NDC | 16110-367 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ACZONE |
| Generic Name | Dapsone |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2022-02-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021794 |
| Labeler Name | ALMIRALL, LLC |
| Substance Name | DAPSONE |
| Active Ingredient Strength | 50 mg/g |
| Pharm Classes | Sulfone [EPC], Sulfones [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-02-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-3670 | ACZONE | dapsone |
| 0023-5206 | ACZONE | dapsone |
| 16110-367 | ACZONE | dapsone |
| 16110-526 | Aczone | dapsone |
| 0378-4830 | Dapsone | Dapsone |
| 0904-7018 | DAPSONE | Dapsone |
| 0904-7019 | DAPSONE | Dapsone |
| 10135-654 | DAPSONE | Dapsone |
| 10135-655 | DAPSONE | Dapsone |
| 13668-605 | dapsone | dapsone |
| 13925-504 | Dapsone | Dapsone |
| 13925-505 | Dapsone | Dapsone |
| 16714-956 | Dapsone | Dapsone |
| 29033-036 | Dapsone | Dapsone |
| 29033-037 | Dapsone | Dapsone |
| 42291-298 | Dapsone | Dapsone |
| 42291-299 | Dapsone | Dapsone |
| 43353-222 | Dapsone | Dapsone |
| 43353-223 | Dapsone | Dapsone |
| 47781-333 | Dapsone | dapsone |
| 47781-334 | Dapsone | dapsone |
| 49938-101 | Dapsone | Dapsone |
| 49938-102 | Dapsone | Dapsone |
| 51672-1387 | Dapsone | Dapsone |
| 51672-1388 | Dapsone | Dapsone |
| 51672-4197 | Dapsone | Dapsone |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ACZONE 78360867 3419732 Live/Registered |
ALMIRALL, LLC 2004-02-02 |